Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Comparing two self-regulation strategies for weight management in adults with overweight

Tests whether choosing a self-control strategy helps adults with overweight or obesity manage weight.

Plain-language title generated from the registry record
Registry title: CHOICE to AVOID or RESIST

Key facts

Where
Beverly Hills, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT06521021, who can take part

Where in United States

  • Cedars-Sinai Medical CenterBeverly Hills, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Cedars-Sinai Medical Center
Trial code
NCT06521021
Record updated
22 September 2026
Original description
This trials will formally test whether participants' active choice of self-regulatory strategies (AVOID or RESIST) leads to greater adherence to weight management strategies by comparing the CHOICE arms to the randomized arms of the parent intervention, AVOID/RESIST (IRB STUDY00001652: AVOID-RESIST).Read full original descriptionShow less

CHOICE to AVOID or RESIST: Evaluating Participants' Choice of Self-regulatory Strategy on Weight Management Outcomes: A Pilot Study.

This trials will formally test whether participants' active choice of self-regulatory strategies (AVOID or RESIST) leads to greater adherence to weight management strategies by comparing the CHOICE arms to the randomized arms of the parent intervention, AVOID/RESIST (IRB STUDY00001652: AVOID-RESIST).

Inclusion: Age 18 years or older; BMI between 25-45 kg/m2; Read, write, and speak English with acceptable visual acuity.

Exclusion: Currently enrolled in weight loss interventions or undergoing bariatric surgery; Individuals for whom weight loss may be contraindicated (e.g., unstable coronary artery disease, end-stage disease, active cancer treatment, uncontrolled insulin-dependent diabetes, portal hypertension, drug/alcohol abuse); Individuals with severe cognitive delays or visual/hearing impairment; Pregnant women; Individuals who have pacemakers or other electronic medical device implantations; Individuals who are unable or unwilling to complete the study assessments / measurements; Individuals currently subscribed to a meal delivery service who are unwilling to pause their subscription for the duration of the study.

ClinicalTrials.gov NCT06521021